We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK, Sanofi Kick Off Phase 2 Vaccine Trial Following December Delay
GSK, Sanofi Kick Off Phase 2 Vaccine Trial Following December Delay
GlaxoSmithKline (GSK) and Sanofi have launched a phase 2 study evaluating their adjuvanted recombinant COVID-19 candidate, after delaying the trial by more than two months.